Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysis

By afschroeder • June 8, 2025

Fichtenbaum CJ, Malvestutto CD, Watanabe MG, Davies Smith E, Ribaudo HJ, McCallum S, Fitch KV, Currier JS, Diggs MR, Chu SM, Aberg JA, Lu MT, Valencia J, Gómez-Ayerbe C, Brar I, Valdez Madruga J, Bloomfield GS, Douglas PS, Zanni MV, Grinspoon SK; REPRIEVE Investigators. Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysis. Lancet HIV. 2025 Jun 4:S2352-3018(25)00043-8. doi: 10.1016/S2352-3018(25)00043-8. Epub ahead of print. PMID: 40482662.

Tags: Infectious Diseases, Publications

Determinants of PrEP Delivery Platform Choice in Adolescents and Young People: The Fast-PrEP Project in Cape Town, South Africa

Rousseau E, Bondarchuk C, Lebelo K, Matsebula L, Bennin F, Macdonald P, Pike C, Vanto O, Mathole N, Fynn L, Davey DJ, Coakley C, Wallace[...]

Proteomic Immune Signatures of Severe HIV-Associated Tuberculosis in Sub-Saharan Africa: A Prospective, Multicenter Analysis From Uganda

Ross JE, Tomoiaga AS, Owor N, Lu X, Shinyale J, Kiyingi T, Asasira I, Eliku PJ, Nsubuga JB, Nsereko C, Nayiga I, Kyebambe S, Ochar[...]

“Someone could have told me”: a qualitative study on experiences with hysterectomy decision-making and regret in Mysore, India

Herbst de Cortina S, Karanam R, Pramathesh R, Begum F, Jaykrishna P, Srinivas V, Hariprasad R, Madhivanan P, Adsul P, Somaiya D. "Someone could have[...]